BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Plexium

Plexium logo

Founded
2018
Patents
12
Publications
2

Technologies

DNA-Encoded Library Companies Protein Degraders Startups

Plexium is a biotech startup focused on developing modulators of E3 ligases for the treatment of cancer, immune and neurological diseases. Plexium utilizes DELPhe platform that enables cell-based phenotypic screening of DNA-encoded libraries. Their technology miniaturizes screening to the scale of picoliter volumes.

Posts Mentioning This Company

A Market Review of DNA-encoded Libraries Technology in Drug Discovery

  
(Last updated: October 05, 2022) The interest of pharma organizations in DNA-encoded chemical libraries (DEL) technology has been growing over the years, with numerous pharma organizations now having their internal screening programs using DELs or outsourcing capabilities from specialized DEL providers. This report provides a bird's view of the DEL …
SHARE